The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management
Usher, K., Foster, K., and Park, T. (2006) The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management. Journal of Psychiatric and Mental Health Nursing, 13 (6). pp. 730-734.
|PDF (Published Version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://dx.doi.org/10.1111/j.1365-2850.20...
The introduction of second-generation antipsychotic drugs for the treatment of schizophrenia has provided significant benefits for clients experiencing this disorder. While they have been found effective in reducing psychotic symptoms, there is evidence that these drugs are also linked with a group of side effects commonly known as the metabolic syndrome. Mental health nurses are well positioned to prevent, detect and/or manage the development of this problematic constellation of symptoms. Guidelines for practice can be useful in prevention and management of the syndrome and enhance nursing care of clients who are taking second-generation antipsychotics.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||diabetes; metabolic syndrome; obesity; second-generation antipsychotic drugs; syndrome X|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1110 Nursing > 111005 Mental Health Nursing @ 100%|
|SEO Codes:||92 HEALTH > 9202 Health and Support Services > 920210 Nursing @ 100%|
|Deposited On:||24 Nov 2009 11:30|
|Last Modified:||23 May 2013 00:35|
Last 12 Months: 192
|Citation Counts with External Providers:||Web of Science: 16|
Repository Staff Only: item control page